Clinical trials
Phase 2 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
124 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 10 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Unknown status | 28 |
| Recruiting | 15 |
| Terminated | 11 |
| Not yet recruiting | 7 |
| Active, not recruiting | 5 |
| Withdrawn | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 7 |
| Ruijin Hospital | 5 |
| Fudan University | 4 |
| National Cancer Institute (NCI) | 4 |
| M.D. Anderson Cancer Center | 3 |
| Sun Yat-sen University | 3 |
| Acrotech Biopharma Inc. | 2 |
| Affimed GmbH | 2 |
| Auxilio Mutuo Cancer Center | 2 |
| Dizal Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 124 |
| Lymphoma, T-Cell, Cutaneous | 29 |
| Lymphoma, Large B-Cell, Diffuse | 24 |
| Lymphoma, Large-Cell, Anaplastic | 24 |
| Immunoblastic Lymphadenopathy | 22 |
| Lymphoma, Non-Hodgkin | 21 |
| Recurrence | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 20 |
| Lymphoma, Extranodal NK-T-Cell | 20 |
| Hodgkin Disease | 19 |
Trials
Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.
24 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.